SRA Wins $18 Million Contract to Support Vaccine Adverse Event Reporting System
FAIRFAX, Va., Nov. 17, 2014 /PRNewswire/ — SRA International, Inc…was awarded a contract to support the Vaccine Adverse Event Reporting System (VAERS) co-sponsored by the Centers for Disease Control and Prevention and the Food and Drug Administration. The contract includes a base year plus four option years and is valued at $18 million if all options are exercised.

VAERS “is a national vaccine safety surveillance program that collects reports from vaccine manufacturers, providers, and recipients about possible side effects, or adverse events, that occur after the administration of vaccines licensed for use in the United States. VAERS searches the reports to: 1) detect new, unusual, or rare vaccine adverse events; 2) monitor increases in known adverse events; 3) identify potential patient risk factors for particular types of adverse events; 4) identify vaccine lots with increased numbers or types of reported adverse events; and 5) assess the safety of newly licensed vaccines.”

Under the contract, SRA will apply a wide range of skills and expertise to support the system including application development and maintenance, data processing/management, medical coding, clinical research, information technology and outreach to the public, vaccine manufacturers and immunization programs…